Neil Osheroff

33PUBLICATIONS

39CO-AUTHORS

Microbial geneticsPharmacogenomicsBiofabricationGenomicsInfectious agents

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|May 27, 2026

Bacterial type II topoisomerases cleave DNA in a species-specific manner.

|Jan 27, 2026

Enzyme-DNA Interactions Affect the Catalytic Inhibition of Mycobacterial Gyrases by Antibacterial Drugs.

Jillian F Armenia, Neil Osheroff

|Jan 10, 2026

Gyrase and Topoisomerase IV as Antibacterial Targets for Gepotidacin and Zoliflodacin: Teaching Old Enzymes New Tricks.

Neil Osheroff

|Dec 23, 2025

Activities of the Novel Bacterial Topoisomerase Inhibitor OSUAB-0284 against the Biothreat Pathogen <i>Bacillus anthracis</i> and Its Type II Topoisomerases.

Chelsea A Mann, Stephanie A Halasohoris, Annette M Gray

|Oct 09, 2025

Mechanism of Action of Gepotidacin: Well-Balanced Dual-Targeting against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV in Cells and In Vitro.

Alexandria A Oviatt, Jessica A Collins, Chelsea A Mann

|Aug 06, 2025

Bacterial type II topoisomerases cleave DNA in a species-specific manner.

Ian L Morgan, Jeffrey Y Jian, Neil Osheroff

Pageof 6

Frequent Collaborators

Jessica A Collins

Alexandria A Oviatt

Mark J Mitton-Fry

Elizabeth G Gibson

Keir C Neuman

Gregory S Basarab

Kelly Chibale

Ben Bax

Marco De Vivo

Jillian F Armenia

Frequent Collaborators

Jessica A Collins

Alexandria A Oviatt

Mark J Mitton-Fry

Elizabeth G Gibson